Delivery Order SPE2DB24D1021-SPE2DB25FFAWL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,921.66 to AmerisourceBergen Drug Corp for Itraconazole 100 mg capsules (30-count) on June 3, 2025, with an ultimate completion date of June 4, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $4,358.00 to AmerisourceBergen Drug Corp for the supply of Itraconazole 100 mg capsules (30-count units) on September 19, 2025, with an ultimate completion date of September 22, 2025. The contract employs firm fixed pricing and was competitively awarded with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Itraconazole 10 mg/ml solution in 150 ml quantities, with a ceiling value of $1,538.96. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a non-competitive, non-set-aside contract action under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Itraconazole 10 mg/ml solution in a 150 ml quantity, with a ceiling value of $10,858.92. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of AmBisome 50 mg vials, a critical antifungal medication used in military and federal healthcare settings. This non-set-aside, competitively awarded delivery order carries a ceiling value of $1,291.80 under firm fixed price terms, with a completion date of September 22, 2025. The contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,911.53 to AmerisourceBergen Drug Corp for the supply of Posaconazole DR 100 mg tablets (60-count units) on July 25, 2025, with completion targeted for July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- The Department of Defense Medical Supply Chain awarded a $37,971.85 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Posaconazole DR 100 mg tablets (60-count units). This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, representing a non-set-aside competitive award. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a $9,532.30 delivery order to AmerisourceBergen Drug Corp for 50 mg vials of AmBisome, a critical antifungal medication used in military and federal healthcare systems. This firm fixed-price contract, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be...
- The Defense Logistics Agency awarded a $15,714.54 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Itovebi 3 mg tablets (28-count packaging) with a completion date of September 22, 2025. This firm fixed-price contract carries no set-aside designation and represents a competitive award to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order is...
- The Defense Logistics Agency awarded a $2,055.80 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Posaconazole 300 mg/16.7 ml vials. The contract, with an ultimate completion date of July 21, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.999 billion through December 2026. This award carries no set-aside...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAWLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Itraconazole 100 mg capsules in quantities of 30 units at a firm fixed price of $1,081.51. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supply support to federal health systems, including the Defense Health Agency, U.S. Coast Guard, and military healthcare programs. As a prime contractor under the DLA's comprehensive pharmaceutical support vehicle, the company supplies a broad portfolio of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare needs globally. This particular delivery order for antifungal medication reflects the routine pharmaceutical replenishment activities executed under the larger prime vendor contract that enables flexible and responsive medical supply chain management across the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/19/25 |